RecruitingISRCTN11236443
Sodium oxybate as a potential new treatment for catatonia in patients with depression, Bipolarity or a psychotic disorder
Research studyAges 18+Netherlands
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- Netherlands
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Amsterdam UMC Location VUmc
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Netherlands
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN11236443
- Official title
Show the full official title
Sodium oxybate as a potential new treatment for catatonia in patients with depression, Bipolarity or a psychotic disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Netherlands
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Amsterdam UMC Location VUmc.
Who can participate?
This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
Sodium oxybate as a potential new treatment for catatonia in patients with depression, Bipolarity or a psychotic disorder, a randomized controlled trial. The Laborit study.
Ketosis and symptoms in schizophrenia and bipolarity
